Detalhe da pesquisa
1.
Genomic Analysis of Hematopoietic Stem Cell at the Single-Cell Level: Optimization of Cell Fixation and Whole Genome Amplification (WGA) Protocol.
Int J Mol Sci
; 21(19)2020 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33036143
2.
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model.
Leukemia
; 37(5): 1068-1079, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928007
3.
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis.
Antioxidants (Basel)
; 11(1)2022 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35052617
4.
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis.
NPJ Precis Oncol
; 5(1): 4, 2021 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542466
5.
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis.
Cancers (Basel)
; 13(19)2021 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638230
6.
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis.
Blood Adv
; 5(5): 1452-1462, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33666652
7.
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants.
Sci Rep
; 9(1): 10558, 2019 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332222
8.
Role of TGF-ß1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
Mol Oncol
; 12(12): 2102-2123, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259659
9.
Calreticulin Affects Hematopoietic Stem/Progenitor Cell Fate by Impacting Erythroid and Megakaryocytic Differentiation.
Stem Cells Dev
; 27(4): 225-236, 2018 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29258411
10.
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.
Blood Cancer J
; 7(12): 638, 2017 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217833
11.
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
Oncotarget
; 8(30): 49451-49469, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533480